Fentanyl Spread ‘Alarming,’ Washington Hearing is Told

A U.S. Sentencing Commission hearing was told Tuesday that customs and border patrol agents had seen a “dramatic increase in seizures” of fentanyl and its analogs, from one kilogram in fiscal year 2013, to 208 kilograms in 2016, to 550 kilograms in 2017—a 160 percent increase over the previous year.


Sessions Backs Stronger DEA Role in Combating Opioid Crisis

The Attorney General tells a news conference that “effective enforcement” should be a priority for new legislation. He also announced a new DEA Division for the Appalachian region, and the appointment of Kellyanne Conway, one of President Trump’s top advisers, to oversee White House initiatives to combat opioid abuse. 

archive archive

Can the U.S. Halt the ‘Unprecedented’ Opioid Epidemic?

The crisis, which took over 64,000 lives last year, shows no sign of abating, according to a report by the Police Executive Research Forum. The report, based on an April conference of police chiefs and other law enforcement officials, said innovative strategies such as partnerships between police and healthcare providers could prevent the epidemic from spreading.

archive archive archive

Trump Vows To Fight Addiction: Where’s the Money?

President Trump spoke at a White House meeting with recovering addicts. Dr. Leana Wen, Baltimore’s health commissioner, said, “We need to move beyond rhetoric. We know what works when it comes to treating the disease of addiction. We now need the resources to be able to combat this epidemic.”


Sen. McCaskill Investigating Opioid Manufacturers

The Missouri Democrat wants five top firms to disclose internal studies that may have detailed the possible risks of addiction and abuse associated with painkillers such as OxyContin and other powerful opioid medications, as well as marketing and business plans to increase sales of opioids.


Addiction and the Next Attorney General

The nation’s devastating opioid ftepidemic should be high on the list of topics raised at the confirmation hearings for AG-designate Jeff Sessions. Here’s how Sessions could rise to the challenge.


Selling OxyContin: How Abbott Labs Engendered Opioid Crisis

Abbott partnered with Purdue Pharma, the company that developed OxyContin, in the aggressive marketing of the powerful painkiller to medical professionals. The explosion of OxyContin abuse is blamed by many for planting the seeds of today’s opioid crisis. Abbott’s efforts pushed sales of OxyContin from $49 million in its first full year on the market to $1.6 billion in 2002.